Background. Clostridium difficile infection (CDI) is the most commonly recognized cause of recurrent diarrhea. Bezlotoxumab, administered concurrently with antibiotics directed against C. difficile ...

Treatment with abelacimab could result in potential cost-savings of $50,000 over a lifetime per patient basis and higher quality-adjusted life years in atrial fibrillation patients at a high risk of ...

CAR-T therapy's cost per QALY is approximately $100,000, with consistent results across PSM, STM, and DES models. DES uniquely incorporates wait time, significantly affecting CAR-T's ...

A joint model combining decision tree with partitioned survival models was developed. A two-round consensus panel was performed to describe clinical practice of Spanish reference centers, providing ...

Introduction Prior to 2020, treatment options for multidrug-resistant tuberculosis (MDR-TB) were limited and typically ...

Several new treatment combinations have been approved in metastatic renal cell carcinoma (mRCC). To determine the optimal therapy on the basis of cost and health outcomes, we performed a ...

Relative to a policy of no treatment, tibolone 2.5 mg/day was found to be an economically attractive treatment modality in Sweden for postmenopausal women who face a high risk of osteoporotic ...

A hypothetical cohort of women, assumed to be initially free of osteoporosis-related bone fractures, is followed on an annual basis for 25 years. Women in the cohort face risks for three important ...

A new study claims a certified registered nurse anesthetist working as the sole anesthesia provider is the most cost-effective model of anesthesia delivery and doesn't impact care quality, according ...

A new study claims a certified registered nurse anesthetist working as the sole anesthesia provider is the most cost-effective model of anesthesia delivery and doesn’t impact care quality, according ...